WASHINGTON – Pharmacies and industry organizations have until November 23 to submit input on proposed federal standards that could reshape Medicare Part D pharmacy reimbursement, network participation, and contracting practices starting in 2029.
The Centers for Medicare & Medicaid Services (CMS) is seeking public comments as it develops standards that define reasonable and relevant pharmacy contract terms under reforms enacted in the Consolidated Appropriations Act of 2026.
The September 24 request for information examines whether current reimbursement rates and dispensing fees adequately cover pharmacies’ medication acquisition and operating costs. CMS is also reviewing pharmacy benefit manager (PBM) contracting practices, payment adjustments, and restrictions on pharmacy network participation.
Under current Medicare Part D regulations, plan sponsors must allow any pharmacy that meets their standard contractual terms to participate in their networks. Although those terms must be reasonable and relevant, CMS has not established detailed standards to define them.
The agency is seeking information on how reimbursement practices affect retail, independent, specialty, and other pharmacies, including whether payment rates reflect actual drug acquisition costs and the costs of dispensing prescriptions.
Other areas under review include pharmacy audits, performance-based payment models, contract modifications, dispute resolution procedures, and post-adjudication payment adjustments that affect final reimbursement.
CMS is also examining whether pharmacies receive sufficient information about reimbursement rates and other financial terms before accepting contracts, as well as the influence of PBMs and vertically integrated organizations on pharmacy network participation.
In a September 29 statement, a coalition of pharmacy organizations welcomed the agency’s review, calling it an important step toward implementing federal PBM reforms and strengthening pharmacy access for Medicare beneficiaries.
The coalition, comprising NACDS, NCPA, the American Pharmacists Association, and other industry groups, emphasized the need for transparent and enforceable contracting standards.
NCPA has urged independent pharmacy owners to submit comments detailing their experiences with Medicare Part D reimbursement and contracting practices.
In an October 27 announcement, the association called for reimbursement that covers medication acquisition and dispensing costs, requires pharmacies to affirmatively accept contract terms, and restricts payment reductions after claims have been processed.
NCPA also seeks to prevent PBMs from conditioning a pharmacy’s participation in Medicare Part D networks on its participation in other PBM networks.
The reforms are part of broader federal efforts to address pharmacy reimbursement pressures, increase transparency in PBM practices, and preserve patients' access to prescription medications.
Under the 2026 law, the Department of Health and Human Services must establish the new contracting standards by April 2028. These requirements will apply to Medicare Part D plan years beginning January 1, 2029.
CMS will use the collected information to inform future regulations and guidance. Comments can be submitted through Regulations.gov under docket CMS-2026-3037 through November 23.
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release